OQROGet OQRO Pro
Insider trade

An2 Therapeutics (ANTX)See Remarks sold ~$3.2K

Joshua M Eizen, See Remarks at An2 Therapeutics, sold ~$3.2K of An2 Therapeutics shares.

~$3.2K
Approx. value · 2,819 sh @ $1.14
177K
Holds after · shares reported
Traded
Nov 4, 2025
Filed
Nov 6, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 4, 2025 · this disclosureInsiderOfficer sold ~$3.2K of ANTX shares in the open market

What came next

  1. Nov 4, 2025InsiderOfficer sold ~$872 of ANTX shares in the open market
  2. Nov 12, 2025Company filing · Form 8-K · ResultsReported its results
  3. Jan 5, 2026Insider · 4 peopleInsiders: 4 sales (~$28K)
  4. Jan 6, 2026Insider · 4 peopleInsiders: 4 sales (~$22K)
  5. Jan 26, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 26, 2026, the Board of Directors (the “Board”) of AN2 Therapeutics, Inc. (the “Company”) appointed Sarah Williams as Vice President, Controller and Principal Accounting Officer of the Company.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for An2 Therapeutics

For An2 Therapeutics, OQRO holds 10 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANTX page.

Other recent filings by Joshua M Eizen, See Remarks

The full history of Joshua M Eizen, See Remarks is on the profile page.

How this filing works

Other disclosures at An2 Therapeutics

Everything OQRO holds on this company is on its ANTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data